Business · 27/08/2019
FDA Announces Draft Guidance for Developing Drugs for Male Breast Cancer Treatment
The FDA is releasing a draft guidance for the pharmaceutical industry on developing and labeling cancer drugs for male breast cancer patients, aiming to improve treatment options and clinical management of the disease.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →